Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 13.13
+0.83 (6.75%)
Apr 8, 2026, 12:59 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.56 billion as of April 7, 2026. Its market cap has decreased by -2.71% in one year.
Market Cap
1.56B
Enterprise Value
1.26B
Revenue
64.65M
Ranking
n/a
PE Ratio
52.86
Stock Price
13.13
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.56B, an increase of 7,343.49%. That is a compound annual growth rate of 22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.52B | -35.36% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.39B |
| Mesoblast | 2.75B |
| Clarity Pharmaceuticals | 1.17B |
| PYC Therapeutics | 1.10B |
| Opthea | 738.77M |
| Racura Oncology | 479.29M |
| Clinuvel Pharmaceuticals | 452.81M |
| Tetratherix | 220.32M |